Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July 2023
MMWR Morb Mortal Wkly Rep
.
2023 Sep 15;72(37):1010-1015.
doi: 10.15585/mmwr.mm7237e1.
Authors
Ashley L Fowlkes
,
Francisco Nogareda
,
Annette Regan
,
Sergio Loayza
,
Jose Mendez Mancio
,
Lindsey M Duca
,
Paula Couto
,
Juliana Leite
,
Angel Rodriguez
,
Daniel Salas
,
Eduardo Azziz-Baumgartner
;
REVELAC–i Network
Collaborators
REVELAC–i Network
:
Estefania Benedetti
1
,
Andrea Pontoriero
1
,
Maria Del Valle Juarez
2
,
Nathalia Katz
2
,
Maria Paz Rojas Mena
2
,
Carla Jimena Voto
2
,
Walquiria Aparecida Ferreira da Almeida
3
,
Daiana Araújo da Silva
3
,
Greice Madeleine Ikeda do Carmo
3
,
Francisco José de Paula Júnior
3
,
Miriam Teresinha Furlam Prando Livorati
3
,
Hellen Kássia Rezende Silva
3
,
Marcela Avendaño
4
,
María Fernanda Olivares Barraza
4
,
Patricia Bustos
4
,
Paula Rodríguez Ferrari
4
,
Natalia Vergara Mallegas
4
,
Rodrigo Fasce Pineda
4
,
Silvia Battaglia
5
,
Marta Von Horoch
5
,
Chavely Domínguez
5
,
Maria José Ortega
5
,
Elena Penayo
5
,
Cynthia Vázquez
5
,
Hector Chiparelli
6
,
Natalia Goñi
6
,
Karina Griot
6
,
Jose Eduardo Silvera
6
,
Daiana Tritten
6
,
Steven Tapia Villacís
6
Affiliations
1
INEI-ANLIS-Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
2
Ministry of Health, Buenos Aires, Argentina.
3
Ministry of Health, Brasília, Brazil.
4
Ministry of Health, Santiago, Chile.
5
Ministry of Public Health and Social Welfare, Asunción, Paraguay.
6
Ministry of Public Health, Montevideo, Uruguay.
PMID:
37708084
PMCID:
PMC10511266
DOI:
10.15585/mmwr.mm7237e1
No abstract available
MeSH terms
Humans
Influenza Vaccines*
Influenza, Human* / epidemiology
Influenza, Human* / prevention & control
Substances
Influenza Vaccines